TheEdgeResearch
Home / Stocks / FTXH

First Trust Nasdaq Pharmaceuticals ETF (FTXH)

NASDAQ Financial Services Asset Management - Global
$39.64 ▲ +0.61%
Market Cap
$37.7M
Sector
Financial Services
Industry
Asset Management - Global
Beta
0.46
52-Wk Range
26.07-42.87
CEO
Country
US
Currency
USD

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.

Open full interactive analysis & DCF →